US EditionPublished • loading... • Updated
Shaping The Future of Obesity Care A Discussion with Annegret Van der Aa
Summary by Inside Precision Medicine
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Shaping The Future of Obesity Care A Discussion with Annegret Van der Aa
Drug developers have long pursued the elusive goal of safely increasing energy expenditure to treat metabolic conditions and obesity. Leiden-based Cantoni Therapeutics is hoping to achieve this goal with its novel small molecule inhibitors of nicotinamide N-methyltransferase (NNMT), which have the potential to treat obesity and improve metabolism without loss of muscle mass. The promise of the technology and pathway is something that attracted A…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
